Bioconvergence

This article contains wording that promotes the subject in a subjective manner without imparting real information. Please remove or replace such wording and instead of making proclamations about a subject's importance, use facts and attribution to demonstrate that importance. (January 2023) (Learn how and when to remove this message)

Bioconvergence is a multidisciplinary approach in life sciences that leverages the integration of biotechnology, engineering, and computers to address complex challenges. This method is used in diagnostic processes, and the development of materials and pharmaceuticals.^[1] In addition to healthcare, bioconvergence contributes to improvements in sectors such as agriculture, energy, food, security, and climate.^[2] Research by McKinsey indicates that the majority of bioconvergence's impact will be felt outside the healthcare sector, including areas like agriculture, aquaculture, consumer products, novel materials, chemistry, and energy. McKinsey estimates that bioconvergence solutions currently under development could generate an economic impact of up to US$4 trillion annually within the next 10 to 20 years.^[3]